CD9 and acute myeloid leukemia: In another study carried by El-Sissy AH et al, CD9 was the most common lymphoid antigen in AML and the most common subtype of AML in which aberrancy was reported was M3 while our study showed aberrant expressions were most commonly found in AML-M2.20 The variation may be reflected due to the cohorts’ age difference.